Cargando…

A Mouse Model of Proliferative Vitreoretinopathy Induced by Intravitreal Injection of Gas and RPE Cells

PURPOSE: Develop a reproducible proliferative vitreoretinopathy (PVR) mouse model that mimics human PVR pathology. METHODS: Mice received intravitreal injections of SF(6) gas, followed by retinal pigment epithelial cells 1 week later. PVR progression was monitored using fundus photography and optica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heffer, Alison, Wang, Victor, Sridhar, Jayanth, Feldon, Steven E., Libby, Richard T., Woeller, Collynn F., Kuriyan, Ajay E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Association for Research in Vision and Ophthalmology 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414640/ https://www.ncbi.nlm.nih.gov/pubmed/32832216 http://dx.doi.org/10.1167/tvst.9.7.9

Ejemplares similares

Salinomycin inhibits proliferative vitreoretinopathy formation in a mouse model
por: Heffer, Alison M., et al.
Publicado: (2020)

TNF-α and NF-κB signaling play a critical role in cigarette smoke-induced epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy
por: Wang, Victor, et al.
Publicado: (2022)

The polyether ionophore salinomycin targets multiple cellular pathways to block proliferative vitreoretinopathy pathology
por: Heffer, Alison M., et al.
Publicado: (2019)

Intravitreal methotrexate infusion for proliferative vitreoretinopathy
por: Sadaka, Ama, et al.
Publicado: (2016)

Intravitreal methotrexate for the treatment of proliferative vitreoretinopathy
por: Benner, Jeffrey David, et al.
Publicado: (2019)

Myo/Nog Cells Give Rise to Myofibroblasts During Epiretinal Membrane Formation in a Mouse Model of Proliferative Vitreoretinopathy
por: Crispin, Mara, et al.
Publicado: (2023)

RPE epithelial-mesenchymal transition plays a critical role in the pathogenesis of proliferative vitreoretinopathy
por: Li, Xiaohua, et al.
Publicado: (2020)

Aerosolized, Gas-Phase, Intravitreal Methotrexate Reduces Proliferative Vitreoretinopathy in a Randomized Trial in a Porcine Model
por: Olsen, Timothy W., et al.
Publicado: (2023)

TSHR Signaling Stimulates Proliferation Through PI3K/Akt and Induction of miR-146a and miR-155 in Thyroid Eye Disease Orbital Fibroblasts
por: Woeller, Collynn F., et al.
Publicado: (2019)

Analysis of Funding Source and Spin in the Reporting of Studies of Intravitreal Corticosteroid Therapy for Diabetic Macular Edema: A Systematic Review
por: Nithianandan, Harrish, et al.
Publicado: (2020)

MeCP2‐421‐mediated RPE epithelial‐mesenchymal transition and its relevance to the pathogenesis of proliferative vitreoretinopathy
por: Li, Xiaohua, et al.
Publicado: (2020)

Vitreous M2 Macrophage-Derived Microparticles Promote RPE Cell Proliferation and Migration in Traumatic Proliferative Vitreoretinopathy
por: Song, Yinting, et al.
Publicado: (2021)

More than Meets the Eye: The Aryl Hydrocarbon Receptor is an Environmental Sensor, Physiological Regulator and a Therapeutic Target in Ocular Disease
por: Hammond, Christine L., et al.
Publicado: (2022)

Proliferative Vitreoretinopathy and Genetic Profile
por: Ghasemi Falavarjani, Khalil
Publicado: (2013)

Proliferative Vitreoretinopathy: A Reappraisal
por: Carpineto, Paolo, et al.
Publicado: (2023)

Silibinin Prevents TGFβ-Induced EMT of RPE in Proliferative Vitreoretinopathy by Inhibiting Stat3 and Smad3 Phosphorylation
por: Ma, Xinqi, et al.
Publicado: (2023)

Proton pump inhibitors attenuate myofibroblast formation associated with thyroid eye disease through the aryl hydrocarbon receptor
por: Hammond, Christine L., et al.
Publicado: (2019)

The aryl hydrocarbon receptor pathway controls matrix metalloproteinase-1 and collagen levels in human orbital fibroblasts
por: Roztocil, Elisa, et al.
Publicado: (2020)

MicroRNA-130a Is Elevated in Thyroid Eye Disease and Increases Lipid Accumulation in Fibroblasts Through the Suppression of AMPK
por: Hammond, Christine L., et al.
Publicado: (2021)

Use of Intravitreal Methotrexate Infusion in Complicated Retinal Detachment for Prevention of Proliferative Vitreoretinopathy in a Pilot Study
por: Jahangir, Sana, et al.
Publicado: (2021)

Vitrectomy with Silicone Oil Tamponade and Single-Dose Intravitreal Methotrexate for Recurrent Retinal Detachment with Proliferative Vitreoretinopathy
por: Babel, Adrian, et al.
Publicado: (2022)

Intravitreal methotrexate infusion for prophylaxis of proliferative vitreoretinopathy after pars plana vitrectomy for rhegmatogenous retinal detachment
por: Fouad Aziz, Joseph Hany, et al.
Publicado: (2022)

The proteomic profile of a mouse model of proliferative vitreoretinopathy
por: Márkus, Bernadett, et al.
Publicado: (2017)

Proliferative vitreoretinopathy: current and emerging treatments
por: Sadaka, Ama, et al.
Publicado: (2012)

The impact of octreotide in experimental proliferative vitreoretinopathy
por: Evren, Ozge, et al.
Publicado: (2013)

Fulminant proliferative vitreoretinopathy in syphilitic uveitis
por: Queiroz, Rafael de Pinho, et al.
Publicado: (2016)

Subretinal Perfluorocarbon Liquid for Dissection of Proliferative Vitreoretinopathy
por: Dalma-Weiszhausz, Jose, et al.
Publicado: (2012)

Evaluation of retinectomy in the treatment of severe proliferative vitreoretinopathy
por: Mendes, Thaís Sousa, et al.
Publicado: (2015)

Retinal shortening: Ultrasonic evaluation of proliferative vitreoretinopathy
por: Takkar, Brijesh, et al.
Publicado: (2017)

Biological Involvement of MicroRNAs in Proliferative Vitreoretinopathy
por: Kaneko, Hiroki, et al.
Publicado: (2017)

Inflammatory and Fibrogenic Factors in Proliferative Vitreoretinopathy Development
por: Chaudhary, Rishika, et al.
Publicado: (2020)

Inflammatory mediators of proliferative vitreoretinopathy: hypothesis and review
por: Dai, Ying, et al.
Publicado: (2020)

Anatomical and Functional Outcomes of Vitrectomy with/without Intravitreal Methotrexate Infusion for Management of Proliferative Vitreoretinopathy Secondary to Rhegmatogenous Retinal Detachment
por: El Baha, Samir, et al.
Publicado: (2021)

Assessment of the innate and adaptive immune system in proliferative vitreoretinopathy
por: Zhang, W, et al.
Publicado: (2012)

Mechanisms of Inflammation in Proliferative Vitreoretinopathy: From Bench to Bedside
por: Moysidis, Stavros N., et al.
Publicado: (2012)

Aquaporin-1 Expression in Proliferative Vitreoretinopathy and in Epiretinal Membranes
por: Motulsky, Elie, et al.
Publicado: (2014)

Outcomes of Vitrectomy in Pediatric Retinal Detachment with Proliferative Vitreoretinopathy
por: Rejdak, Robert, et al.
Publicado: (2017)

Commentary: Management of proliferative vitreoretinopathy in recurrent retinal detachment
por: Babu, Naresh, et al.
Publicado: (2020)

Doxycycline Ameliorates the Severity of Experimental Proliferative Vitreoretinopathy in Mice
por: Chen, Shun-Hua, et al.
Publicado: (2021)

Infographic: Slow-release dexamethasone in proliferative vitreoretinopathy (PVR)
por: Mostafa, I., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oeridh9au4mjhcdrbhh8dm8sv4